NCT06957548

Brief Summary

Cardiometabolic diseases (CMDs) are a major public health concern in sub-Saharan Africa, including Cameroon. Studies have shown a significant increase in the prevalence of hypertension, diabetes, and obesity in recent years. However, access to timely diagnosis and treatment remains limited, particularly in rural areas. Community-based screening programs have been shown to be effective in identifying individuals with undiagnosed CMD risk factors and promoting early intervention. By leveraging the strengths of community-based approaches, the URBACAM-D study aims to address the growing burden of CMDs in urban Cameroon.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
9mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Jul 2025Feb 2027

First Submitted

Initial submission to the registry

April 25, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 4, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

July 9, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 12, 2025

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2027

Expected
Last Updated

November 26, 2025

Status Verified

November 1, 2025

Enrollment Period

3 months

First QC Date

April 25, 2025

Last Update Submit

November 25, 2025

Conditions

Cardiac DiseaseMetabolic Disease

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Cardiometabolic disease risk factors in Urban Cameroon

    To determine the prevalence of undiagnosed and uncontrolled cardiometabolic disease (CMD) risk factors among urban Cameroonians.

    1 year

Interventions

Cardiometabolic diseaseDIAGNOSTIC_TEST

Cardiometabolic disease screening

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Urban Cameroon. Newbell, Douala, cameroon.

You may qualify if:

  • Screening is open to any adult over the age of 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Newbell Protestant Hospital

Douala, Littoral Region, Cameroon

Location

MeSH Terms

Conditions

Heart DiseasesMetabolic Diseases

Condition Hierarchy (Ancestors)

Cardiovascular DiseasesNutritional and Metabolic Diseases

Study Officials

  • Dimitri Tito, DO

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2025

First Posted

May 4, 2025

Study Start

July 9, 2025

Primary Completion

October 12, 2025

Study Completion (Estimated)

February 12, 2027

Last Updated

November 26, 2025

Record last verified: 2025-11

Locations

CA(1)